387 related articles for article (PubMed ID: 14515684)
1. [National evaluation of the diagnosis of activated protein C resistance].
Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
4. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
5. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
7. [Activated protein C resistance as a cause of thrombophilia].
Ruiz-Argüelles GJ
Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
Baig MA
Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
10. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
12. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of phenotype resistance to activated protein C (APC resistance)].
Hudecek J; Ivanková J; Dobrotová M; Hybenová J; Pullmann R; Kubisz P
Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C resistance and factor V Leiden in Mexico.
Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden mutation in one family of Chinese origin.
Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
[TBL] [Abstract][Full Text] [Related]
17. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
Moland L; Sandset PM
Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
19. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
[TBL] [Abstract][Full Text] [Related]
20. [Primary thrombophilia in México. VI: lack of statistical association among the inherited thrombophilic conditions].
Ruiz-Argüelles GJ; González-Carrillo ML; Estrada-Gómez R; Valdés-Tapia P; Parra-Ortega I; Porras-Juárez A
Gac Med Mex; 2007; 143(4):317-22. PubMed ID: 17969840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
